Metabolic syndrome and its components after liver transplantation: incidence, prevalence, risk factors, and implications.
Metabolic syndrome is defined as the mutual existence of obesity, impaired fasting glucose levels, insulin resistance, hypertension, and dyslipidemia. After liver transplantation, patients typically develop these disorders, and even though there has been minimal research focused on the chronic impact of this syndrome on post-liver transplant patients, studies point to an association with major vascular events and fibrosis. The aim of the current work is to review data on the incidence, prevalence, risk factors, and implications of metabolic syndrome and its components in patients who have undergone liver transplantation.
Anastácio
Lucilene Rezende
LR
Food Science Post-Graduation Program, Pharmacy School, Alfa Institute of Gastroenterology, School of Medicine, Federal University of Minas Gerais, Brazil.
Lima
Agnaldo Soares
AS
Toulson Davisson Correia
Maria Isabel
MI
D003920:Diabetes Mellitus / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D050171:Dyslipidemias / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D005260:Female; D006801:Humans; D006973:Hypertension / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D007166:Immunosuppressive Agents / Q000009:adverse effects; D015994:Incidence; D007333:Insulin Resistance / Q000502:physiology; D016031:Liver Transplantation / Q000009:adverse effects*; D008297:Male; D024821:Metabolic Syndrome / Q000175:diagnosis / Q000453:epidemiology* / Q000503:physiopathology* / Q000517:prevention & control; D009765:Obesity / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D015995:Prevalence; D012307:Risk Factors
D007166:Immunosuppressive Agents